Compare · head to head
Enanta Pharmaceuticals vs Moderna
Enanta Pharmaceuticals ranks higher overall — 360 rank 62 vs 20.
Enanta Pharmaceuticals leads on Value (48 vs 43), Quality (52 vs 39), Growth (59 vs 46), Safety (47 vs 39) and Sentiment (57 vs 49).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | X-Large |
| ISIN | US29251M1062 | US60770K1079 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 62 | 20 |
| Value | 48 | 43 |
| Quality | 52 | 39 |
| Growth | 59 | 46 |
| Safety | 47 | 39 |
| Sentiment | 57 | 49 |
| Quality details | ||
| Profitability | 55 | 24 |
| Cash Truth | 48 | 53 |
Enanta Pharmaceuticals vs Mirum PharmaceuticalsEnanta Pharmaceuticals vs Krystal BiotechEnanta Pharmaceuticals vs Puma BiotechnologyEnanta Pharmaceuticals vs Kura OncologyAdd a third stock →
Full analyses: Enanta Pharmaceuticals · Moderna
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100